Trividia Health announces Preferred Listing of TRUE METRIX meters and strips on Express Scripts’ National Formulary
Providing accurate and confident blood glucose testing for Express Scripts commercial pharmacy benefit services members.
Diabetes
Dexcom G7 15 Day Continuous Glucose Monitoring System to launch on Dec. 1
Dexcom G7 15 Day will first be available through durable medical equipment (DME) providers with full retail launch in the coming weeks.
Danone North America to host Reddit 'Ask Me Anything' to help consumers take control of their health during American Diabetes Month
The AMA is part of a campaign to reach people with free expert information and nutrition resources to help reduce the risk of type 2 diabetes.
UVA Health experts warn GLP-1 drugs may not provide key long-term weight-loss benefit
Doctors may need to consider recommending exercise programs or develop other approaches, such as nutrition supplements or complementary medications, to help GLP-1 patients get the full cardiorespiratory benefits of substantial weight loss over the long-run, the researchers say.
Mattel introduces first-ever Barbie doll with type 1 diabetes
“Introducing a Barbie doll with type 1 diabetes marks an important step in our commitment to inclusivity and representation,” said Krista Berger, senior vice president of Barbie and Global Head of Dolls.
RemeVerse launches breakthrough skincare, haircare & pain relief products for diabetic patients
These products are specifically designed to tackle the skin, hair, and pain issues faced by those with diabetes.
Charles Barkley teams with Ro as GLP-1 Celebrity Ambassador
The NBA legend is spotlighting convenient access to weight loss treatment with Ro.
Dexcom G7 15 Day receives FDA clearance
Dexcom G7 15 Day is now cleared in the U.S. for people age 18 years and above with diabetes.
Global Data forecasts Type 1 diabetes market to reach $9.9 billion by 2033
"According to primary research conducted by GlobalData, high volumes of prescribing physicians and patients have demonstrated positive attitudes towards the use of ultra-rapid insulin analogs, which is expected to drive T1D market growth.”
National Diabetes Awareness Month: Shining a spotlight on Hispanic Americans
As part of National Diabetes Awareness Month, Cardinal Health is focusing on the Hispanic American population, which is one of the top high-risk populations for diabetes.
eddii launches eddii-Care for adults
Following introduction of pediatric care in 37 states, innovative health tech company focused on diabetes management expands virtual care to adults, starting in the states of New Jersey, Washington, and Maryland
ADA teaming with pharmaceutical suppliers to support the needs of people with diabetes
Association working with Abbott and Gentech.
Study: Majority of GLP-1 users discontinue drug early
The survey of people between the ages of 21 and 75 found that more than three-quarters (78%) discussed lifestyle changes with their prescriber before receiving or when receiving a GLP-1 medication.